(Circulation. 2006;114:2773-2779.)
© 2006 American Heart Association, Inc.
Coronary Heart Disease |
B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits
From the Departments of Cardiovascular Medicine (K.O., K.E., K.N., G.Z., Y.I., K.F., K.S.) and Surgery (S.K., R.T.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and Division of Clinical Gene Therapy, Osaka University Medical School, Osaka, Japan (R.M.).
Correspondence to Kensuke Egashira, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail egashira{at}cardiol.med.kyushu-u.ac.jp
Received August 11, 2005; revision received October 10, 2006; accepted October 13, 2006.
Background Nuclear factor-
B (NF-
B) plays a critical role in the vascular response to injury. However, the role of NF-
B in the mechanism of in-stent restenosis remains unclear. We therefore tested the hypothesis that blockade of NF-
B by stent-based delivery of a cis-element "decoy" of NF-
B reduces in-stent neointimal formation.
Methods and Results Stents were coated with a polymer containing or not containing NF-
B decoy, which represented a fast-release formulation (<7 days). Bare, polymer-coated, and NF-
B decoyeluting stents were implanted in iliac arteries of hypercholesterolemic rabbits. Increased NF-
B activity was noted at early stages after stenting, which was suppressed by stent-based delivery of NF-
B decoy. NF-
B decoyeluting stents also reduced monocyte infiltration and monocyte chemoattractant protein-1 expression and suppressed CD14 activation on circulating leukocytes. Importantly, NF-
B decoyeluting stents attenuated neointimal formation on day 28. There was no evidence of an incomplete healing process (persistent inflammation, hemorrhage, fibrin deposition, impaired endothelial regeneration) at the site of NF-
B decoyeluting stents. Transfection of NF-
B decoy suppressed proliferation of human coronary artery smooth muscle cells in vitro. No systemic adverse effects of NF-
B decoy were detected.
Conclusions Stent-based local delivery of NF-
B decoy reduced in-stent neointimal formation with no evidence of incomplete healing. These data suggest that this strategy may be a practical and promising means for prevention of in-stent restenosis in humans.
This article has been cited by other articles:
![]() |
K. Egashira, K. Nakano, K. Ohtani, K. Funakoshi, G. Zhao, Y. Ihara, J.-i. Koga, S. Kimura, R. Tominaga, and K. Sunagawa Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2563 - 2568. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L. J. Feldman Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3593 - H3601. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |